当科の篠原明仁講師の論文が
Transplantation and Cellular Therapyにアクセプトされました。
PMID: 40096889
doi: 10.1016/j.jtct.2025.03.008.
Transplant Cell Ther. 2025 Mar 15:S2666-6367(25)01097-8.
Fludarabine Plus Myeloablative Dose of Busulfan Regimen Was Associated with High Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Lymphoma: A Propensity Score-Matched Comparison Study with Fludarabine Plus High-Dose Melphalan
下記リンクをご参照ください。
